Logo image
The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels
Journal article   Open access   Peer reviewed

The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels

Christopher S Coffey, Folkert W Asselbergs, Patricia R Hebert, Hans L Hillege, Qing Li, Jason H Moore and Wiek H van Gilst
Cardiology research and practice, Vol.2011(1), pp.1-8
2011
DOI: 10.4061/2011/541467
PMCID: PMC3087975
PMID: 21559217
url
https://doi.org/10.4061/2011/541467View
Published (Version of record) Open Access

Abstract

Background. We used a random sample (n=2,495) from the population-based Prevention of Renal and Vascular End-stage Disease (PREVEND) study population to examine the association of the metabolic syndrome (Met S) with plasminogen activator inhibitor type 1 (PAI-1) and tissue plasminogen activator (t-PA) antigen levels.Results. The overall prevalence of the Met S was 18%, was dependent on age and gender, and was positively associated with higher antigen levels of both PAI-1 and t-PA. These significant effects were maintained after adjustment for age, gender, BMI, elevated C-reactive protein, smoking status, urinary albumin excretion, and insulin levels. We found no significant interactions between the Met S and other covariates on PAI-1 and t-PA levels.Conclusions. Our study demonstrates that those with the Met S have significantly higher levels of PAI-1 and t-PA antigen, factors known to increase the risk of cardiovascular disease.

Details

Metrics

Logo image